Latin American Working Group on Gram Positive Resistance, Hospital Vozandes, Quito, Ecuador.
Braz J Infect Dis. 2010 Dec;14 Suppl 2:S97-106. doi: 10.1590/s1413-86702010000800005.
Strategies to monitor and control the spread of methicillin-resistant Staphylococcus aureus (MRSA) infections are dependent on accurate and timely diagnosis of MRSA in both hospital and community settings. In Latin America, significant diversity in diagnostic and susceptibility testing procedures exists at the regional, national and local levels. Various tests for S. aureus and MRSA are available in clinical settings, but the application of these techniques differs between and within countries, and quality control measures are not uniformly applied to verify diagnoses. To optimize the diagnosis of MRSA infections across Latin America, a more consistent approach is required. This may include: adoption and appropriate adaption of specific guidelines for MRSA testing, depending on local resources; establishment of a coordinated system for quality control; regional access to central reference facilities; education of medical and healthcare professionals in best practices; and development of systems to evaluate the implementation of guidelines and best practices.
监测和控制耐甲氧西林金黄色葡萄球菌（MRSA）感染传播的策略取决于在医院和社区环境中对 MRSA 进行准确和及时的诊断。在拉丁美洲，区域、国家和地方各级的诊断和药敏试验程序存在显著差异。临床环境中提供了各种用于检测金黄色葡萄球菌和耐甲氧西林金黄色葡萄球菌的检测方法，但这些技术在国家之间和国家内部的应用存在差异，并且质量控制措施并未统一应用于验证诊断。为了优化拉丁美洲的耐甲氧西林金黄色葡萄球菌感染诊断，需要采用更一致的方法。这可能包括：根据当地资源，采用和适当调整针对耐甲氧西林金黄色葡萄球菌检测的具体指南；建立协调的质量控制体系；区域内获得中央参考设施的机会；对医疗和医疗保健专业人员进行最佳实践教育；以及开发评估指南和最佳实践实施情况的系统。
